Biotheryx: Funding, Investors & Team (Oct 2026)
Biotheryx is a clinical stage biopharmaceutical company discovering and developing a portfolio of innovative small molecule targeted protein degraders (TPDs) for the treatment of a wide range of diseases with an initial focus on cancer. Members of our founding and scientific teams previously developed the first FDA approved modulators of Cereblon, the most widely validated E3 ligase involved in protein degradation, and have applied their expertise in Cereblon binding to build our proprietary PRODEGY platform. Our platform leverages an extensive patent protected and rationally designed library of Cereblon binders that we believe provides us with a differentiated starting point for drug design of molecular glues, bifunctional degraders and hybrid degraders.
Biotheryx has raised $98.0M across 2 funding rounds on record, the most recent an undisclosed round of $6.0M announced in Apr 2023.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Biotheryx Company Profile and Key Stats
Latest funding round on record: Apr 2023.
Biotheryx Funding Rounds
Biotheryx raised $92.0M in an undisclosed round announced in May 2021.
1.9 years later, an undisclosed round of $6.0M was announced in Apr 2023.
Biotheryx Founders and Leadership Team
No contact details are on record for this team yet.
Biotheryx Funding Compared to Other Biotechnology Startups
Biotheryx's latest round of $6.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Biotheryx in Biotechnology and San Diego
Companies Similar to Biotheryx
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Biotheryx Funding FAQs
What does Biotheryx do?
Biotheryx is a clinical stage biopharmaceutical company discovering and developing a portfolio of innovative small molecule targeted protein degraders (TPDs) for the treatment of a wide range of diseases with an initial focus on cancer. Members of our founding and scientific teams previously developed the first FDA approved modulators of Cereblon, the most widely validated E3 ligase involved in protein degradation, and have applied their expertise in Cereblon binding to build our proprietary PRODEGY platform. Our platform leverages an extensive patent protected and rationally designed library of Cereblon binders that we believe provides us with a differentiated starting point for drug design of molecular glues, bifunctional degraders and hybrid degraders.
How much funding has Biotheryx raised?
Biotheryx has raised $98.0M across 2 rounds on record. The most recent is an undisclosed round of $6.0M announced in Apr 2023.
When did Biotheryx last raise funding?
Biotheryx's most recent funding round on record is an undisclosed round of $6.0M, announced in Apr 2023.
Who is the CEO of Biotheryx?
Philippe Drouet is listed as CEO at Biotheryx.
Where is Biotheryx headquartered?
Biotheryx is based in San Diego, California, United States.
How many employees does Biotheryx have?
Biotheryx is in the 11-50 employee band.
How does Biotheryx's funding compare to other Biotechnology startups?
Biotheryx's latest round of $6.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Biotheryx Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Biotheryx is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.